Keyphrases
Tumor
100%
Recurrent Disease
100%
Risk Score
100%
Tongue Cancer
100%
Stromal Myofibroblasts
100%
High Risk
28%
α-smooth muscle Actin (α-SMA)
28%
Local Recurrence
28%
E-cadherin
28%
Carcinoma Cells
28%
Adverse Effects
14%
Multivariate Analysis
14%
Young Age
14%
Confidence Interval
14%
Hazard Ratio
14%
Prognostic Factors
14%
Malignant Cells
14%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
14%
Oral Cancer
14%
Myofibroblast
14%
Overall Survival
14%
Recurrence Risk
14%
Young Patients
14%
Treatment Concept
14%
Epithelial Malignancies
14%
Ki-67
14%
Fisher's Exact Test
14%
Lymphocyte Infiltration
14%
Forward Selection
14%
Multivariate Regression Model
14%
Epithelial-mesenchymal Transition
14%
Histological Parameters
14%
Worst Pattern of Invasion
14%
Perineural Invasion
14%
Positive Margins
14%
Multiplex Immunostaining
14%
Recurrence Hazard
14%
Margin Status
14%
Kaplan-Meier Survival Analysis
14%
Medicine and Dentistry
Recurrent Disease
100%
Neoplasm
100%
Tongue Cancer
100%
Myofibroblast
100%
Carcinoma Cell
25%
Alpha Smooth Muscle Actin
25%
Uvomorulin
25%
Hazard Ratio
12%
Multivariate Analysis
12%
Adverse Event
12%
Immunohistochemistry
12%
Cancer
12%
Oral Cancer
12%
Overall Survival
12%
Tongue Carcinoma
12%
Survival Analysis
12%
Stroma
12%
Fisher Exact Test
12%
Lymphocytic Infiltration
12%
Mesenchymal-Epithelial Transition
12%
Perineural Invasion
12%
Pharmacology, Toxicology and Pharmaceutical Science
Recurrent Disease
100%
Neoplasm
100%
Tongue Cancer
100%
Carcinoma
40%
Uvomorulin
40%
Alpha Smooth Muscle Actin
40%
Adverse Event
20%
Overall Survival
20%
Tongue Carcinoma
20%
Mouth Cancer
20%
Lymphocytic Infiltration
20%
Perineural Invasion
20%
Immunology and Microbiology
Myofibroblast
100%
Tongue
100%
Actin
25%
Carcinoma Cell
25%
Smooth Muscle
25%
Cadherin
25%
Stroma
12%
Immunostaining
12%
Epithelial Mesenchymal Transition
12%
Overall Survival
12%
Biochemistry, Genetics and Molecular Biology
Myofibroblast
100%
Actin
25%
Cadherin
25%
Multivariate Analysis
12%
Immunostaining
12%
Mesenchymal-Epithelial Transition
12%
Overall Survival
12%